Diabetic retinopathy is a leading cause of acquired blindness, and the most common ischemic disorder of the retina. Instead of a pharmacological or surgical approach, researchers have used a strategy of ischemic tolerance induction which provides a robust neuroprotection against retinal diabetic damage. These results suggest that ischemic tolerance could constitute a fertile avenue for the development of new therapeutic strategies in diabetic retinopathy treatment.
↧